Lymph Node Metastasis

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 164727 Experts worldwide ranked by ideXlab platform

Koji Matsuo - One of the best experts on this subject based on the ideXlab platform.

  • significance of Lymph Node Metastasis on survival of women with uterine adenosarcoma
    Gynecologic Oncology, 2017
    Co-Authors: Hiroko Machida, Michael J Nathenson, Tsuyoshi Takiuchi, Crystal L Adams, Jocelyn Garciasayre, Koji Matsuo
    Abstract:

    Abstract Objective Uterine adenosarcoma (UAS) is a rare gynecologic malignancy and the significance of Lymph Node Metastasis on survival has not been well studied. Methods A retrospective study was performed utilizing the Surveillance, Epidemiology, End Results Program to examine UAS (n=994), endometrial stromal sarcoma (ESS, n=2910), and uterine leiomyosarcoma (LMS, n=5506) diagnosed between 1973 and 2013. The impact of Lymph Node Metastasis on cause-specific survival (CSS) was cross-compared by multivariable analysis. Systematic literature review was conducted to examine the impact of nodal Metastasis on progression-free survival (PFS) in UAS. Results UAS had the lowest incidence of Lymph Node Metastasis among the sarcoma subtypes examined (UAS 2.9%, LMS 3.4%, and ESS 6.6%, P P P Conclusion While uterine adenosarcoma had a low incidence of Lymph Node Metastasis, the impact of Lymph Node Metastasis on survival was comparable to ESS or LMS.

  • Significance of Lymph Node Metastasis on survival of women with uterine adenosarcoma.
    Gynecologic oncology, 2017
    Co-Authors: Hiroko Machida, Michael J Nathenson, Tsuyoshi Takiuchi, Crystal L Adams, Jocelyn Garcia-sayre, Koji Matsuo
    Abstract:

    Abstract Objective Uterine adenosarcoma (UAS) is a rare gynecologic malignancy and the significance of Lymph Node Metastasis on survival has not been well studied. Methods A retrospective study was performed utilizing the Surveillance, Epidemiology, End Results Program to examine UAS (n=994), endometrial stromal sarcoma (ESS, n=2910), and uterine leiomyosarcoma (LMS, n=5506) diagnosed between 1973 and 2013. The impact of Lymph Node Metastasis on cause-specific survival (CSS) was cross-compared by multivariable analysis. Systematic literature review was conducted to examine the impact of nodal Metastasis on progression-free survival (PFS) in UAS. Results UAS had the lowest incidence of Lymph Node Metastasis among the sarcoma subtypes examined (UAS 2.9%, LMS 3.4%, and ESS 6.6%, P P P Conclusion While uterine adenosarcoma had a low incidence of Lymph Node Metastasis, the impact of Lymph Node Metastasis on survival was comparable to ESS or LMS.

Zhang Wen-sha - One of the best experts on this subject based on the ideXlab platform.

  • Characteristics of Lymph Node Metastasis in thoracic esophageal carcinoma
    Chinese Journal of Surgical Oncology, 2013
    Co-Authors: Zhang Wen-sha
    Abstract:

    Objective To study the pattern of Lymph Node Metastasis in thoracic esophageal carcinoma and to analyze the factors influencing Lymph Node Metastasis and the Metastasis direction for more reasonable approach of Lymph Nodes dissection.Methods 328 patients with thoracic esophageal squamous cell carcinoma( ESCC) who had undergone radical surgery from April 2010 to July 2012 were analyzed.The pattern of Lymph Node Metastasis was studied by analyzing all the clinical and pathologic materials.Results We re-examined 9937 Lymph Nodes in the group of 328 case on average of 30.3 piece per case.Among the patients,Lymph Node Metastasis occurred in 153 cases,with the rate of 46.65%.Recurrent laryngeal nerve of Lymph Node Metastasis is occupied 18.30%,10.46% by recurrent laryngeal nerve is the only transfer part Lymph Node.The rate of Lymph Node Metastasis of the thoracic ESCC increased with the increase of tumor length,the depth of tumor invasion and the decrease of tumor differentiation.Metastasis to the cervical and high mediastinal Lymph Nodes mainly occurred in patients with the upper thoracic ESCC.Lymph Node Metastasis in the middle thoracic ESCC had upward,downward and skip spread characteristics.Lymph Node Metastasis to the abdominal cavity,middle and low mediastinal mainly occurred in patients with the lower thoracic ESCC.Conclusions We suggest that the upper thoracic ESCC should perform three field Lymphadenectomy with the high rate of Lymph Node Metastasis.For the lower thoracic ESCC should perform two field Lymphadenectomy.The pattern of Lymphadenectomy for the middle thoracic ESCC should be designed according to different situations.With the high rate of Lymph Node Metastasis in the recurrent laryngeal nerve,Lymphadenectomy is necessary.

Hiroko Machida - One of the best experts on this subject based on the ideXlab platform.

  • significance of Lymph Node Metastasis on survival of women with uterine adenosarcoma
    Gynecologic Oncology, 2017
    Co-Authors: Hiroko Machida, Michael J Nathenson, Tsuyoshi Takiuchi, Crystal L Adams, Jocelyn Garciasayre, Koji Matsuo
    Abstract:

    Abstract Objective Uterine adenosarcoma (UAS) is a rare gynecologic malignancy and the significance of Lymph Node Metastasis on survival has not been well studied. Methods A retrospective study was performed utilizing the Surveillance, Epidemiology, End Results Program to examine UAS (n=994), endometrial stromal sarcoma (ESS, n=2910), and uterine leiomyosarcoma (LMS, n=5506) diagnosed between 1973 and 2013. The impact of Lymph Node Metastasis on cause-specific survival (CSS) was cross-compared by multivariable analysis. Systematic literature review was conducted to examine the impact of nodal Metastasis on progression-free survival (PFS) in UAS. Results UAS had the lowest incidence of Lymph Node Metastasis among the sarcoma subtypes examined (UAS 2.9%, LMS 3.4%, and ESS 6.6%, P P P Conclusion While uterine adenosarcoma had a low incidence of Lymph Node Metastasis, the impact of Lymph Node Metastasis on survival was comparable to ESS or LMS.

  • Significance of Lymph Node Metastasis on survival of women with uterine adenosarcoma.
    Gynecologic oncology, 2017
    Co-Authors: Hiroko Machida, Michael J Nathenson, Tsuyoshi Takiuchi, Crystal L Adams, Jocelyn Garcia-sayre, Koji Matsuo
    Abstract:

    Abstract Objective Uterine adenosarcoma (UAS) is a rare gynecologic malignancy and the significance of Lymph Node Metastasis on survival has not been well studied. Methods A retrospective study was performed utilizing the Surveillance, Epidemiology, End Results Program to examine UAS (n=994), endometrial stromal sarcoma (ESS, n=2910), and uterine leiomyosarcoma (LMS, n=5506) diagnosed between 1973 and 2013. The impact of Lymph Node Metastasis on cause-specific survival (CSS) was cross-compared by multivariable analysis. Systematic literature review was conducted to examine the impact of nodal Metastasis on progression-free survival (PFS) in UAS. Results UAS had the lowest incidence of Lymph Node Metastasis among the sarcoma subtypes examined (UAS 2.9%, LMS 3.4%, and ESS 6.6%, P P P Conclusion While uterine adenosarcoma had a low incidence of Lymph Node Metastasis, the impact of Lymph Node Metastasis on survival was comparable to ESS or LMS.

Yan Chen - One of the best experts on this subject based on the ideXlab platform.

  • Clinical Study on Prelaryngeal Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Cancer management and research, 2020
    Co-Authors: Jin Xing Gong, Qi Zhu, Yan Chen
    Abstract:

    Objective This study aims to investigate the risk factors of prelaryngeal Lymph Node Metastasis in papillary thyroid carcinoma and its clinical application value. Methods The clinical pathological features and metastatic risks were statistically analyzed by reviewing 254 patients with papillary thyroid carcinoma, who received their first operation and prelaryngeal Lymph Node dissection in our department. Results The detection of prelaryngeal Lymph Nodes, tumor size and any paratracheal Lymph Node Metastasis were correlated with the number of paratracheal Lymph Node Metastasis (P 0.05). Conclusion Paratracheal Lymph Node Metastasis indicates a high possibility of prelaryngeal Lymph Node Metastasis. Paratracheal Lymph Node dissection combined with prelaryngeal Lymph Node dissection should be simultaneously considered in operations for thyroid papilla carcinoma.

Jin Ye-ning - One of the best experts on this subject based on the ideXlab platform.

  • A Study of CT in Gastric Carcinoma with Solitary Lymph Node Metastasis
    Journal of Oncology, 2009
    Co-Authors: Jin Ye-ning
    Abstract:

    [Purpose] To investigate the role of CT diagnosis for gastric carcinoma with solitary Lymph Node Metastasis. [Methods]The clinical records of 75 cases with solitary Lymph Node Metastasis from gastric carcinoma were analyzed retrospectively.[Results] Of these 75 patients, Lymph Node Metastasis in 68 cases located at perigastric region(N1). There were 7 cases with a jumping Metastasis to the N2~N3 Nodes. The accuracy of CT in T staging, N staging and M staging of gastric carcinoma was 73.3%, 78.7%, and 90% respectively. [Conclusion] Sentinel Node is not every one located at the perigastric region near the primary tumor. CT plays an important role in TNM staging for gastric carcinoma with solitary Lymph Node Metastasis.